Mykhailo Mudryk Cleared to Return to Football

Mykhailo Mudryk’s long wait is over. The Chelsea winger has been cleared to return to competitive football after his doping ban was brought to an end in a case that has exposed how quickly the ground can shift beneath an athlete’s feet.

The 25-year-old has not played since November 2024, frozen out of the game by a four-year suspension for a failed drug test that dated back two years and showed a low concentration of meldonium, a prohibited substance. His career stalled, his reputation questioned, his future uncertain.

Now the rules around him have changed.

Mudryk appealed to the Court of Arbitration for Sport (CAS), and while that process unfolded, the World Anti-Doping Agency (WADA) updated its procedures and scientific reporting standards. Under those new thresholds, the very test that triggered his ban would not have been pursued.

The FA set out the shift in stark terms. It confirmed that changes to anti-doping protocols – though not retroactive in a formal sense – mean that if Mudryk’s sample were taken today, the meldonium level “would not have been reported and no anti-doping rule violations would have resulted”.

That admission altered everything.

With WADA’s agreement, the FA and Mudryk reached a resolution to the appeal. As part of that agreement, the Ukrainian accepted that he had committed the Anti-Doping Rule Violations (ADRVs) originally charged, and he agreed to a period of ineligibility equal to the time he has already served.

In other words, his punishment stands on paper. In practice, it ends here.

“Mr Mudryk is no longer ineligible and may return to competition with immediate effect,” the FA confirmed, drawing a line under a saga that has kept one of European football’s most expensive wingers off the pitch for the best part of a season.

Chelsea, who paid £88m to sign Mudryk from Shakhtar Donetsk in January 2023, moved quickly to frame the decision in the context of evolving science rather than simple absolution. In a club statement, they welcomed the recognition that advances in testing standards meant his original sample, if analysed now, would not have been reported as a positive and no violation would have followed.

For the club, that detail matters. It colours how this episode will be remembered and how Mudryk will be received when he pulls on a blue shirt again.

Chelsea described that scientific shift as “an important part of the context surrounding the agreed resolution” and stressed that it “allows everyone involved to move forward”.

The winger now steps back into a very different Chelsea from the one he left last autumn: a squad reshaped, expectations recalibrated, scrutiny as fierce as ever. His price tag has never stopped following him. Now his absence has a story attached to it as well.

What comes next is simple and ruthless, as football always is: Mudryk must prove that the months spent in limbo have not dulled the explosiveness that persuaded Chelsea to gamble £88m on his potential, and that this turbulent chapter will be a footnote rather than the defining line of his career.